Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by PGGM Investments

PGGM Investments lessened its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 68.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,894 shares of the company's stock after selling 10,683 shares during the period. PGGM Investments' holdings in Bath & Body Works were worth $190,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of BBWI. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works during the 4th quarter valued at about $26,000. SRS Capital Advisors Inc. grew its stake in Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares in the last quarter. True Wealth Design LLC grew its stake in Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after acquiring an additional 1,054 shares in the last quarter. UMB Bank n.a. grew its stake in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after acquiring an additional 431 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Price Performance

Shares of BBWI stock traded up $0.26 during trading hours on Wednesday, hitting $30.24. The company had a trading volume of 5,886,906 shares, compared to its average volume of 4,145,852. The company's fifty day moving average is $36.10 and its 200 day moving average is $33.99. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The stock has a market capitalization of $6.55 billion, a PE ratio of 7.37, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were issued a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.65%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.

Bath & Body Works announced that its board has initiated a share buyback program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Analysts Set New Price Targets

Several brokerages recently issued reports on BBWI. Robert W. Baird upped their price objective on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research note on Friday, February 28th. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $42.00 to $48.00 in a report on Friday, January 10th. TD Cowen boosted their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a "buy" rating in a report on Thursday, December 12th. Morgan Stanley decreased their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a report on Thursday, November 21st. Finally, Cowen reiterated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $45.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.